Preview: Acumen Pharmaceuticals's Earnings
Benzinga Insights 12 months ago
Earnings
Acumen Pharmaceuticals (NASDAQ:ABOS) is set to give its latest quarterly earnings report on Wednesday, 2025-11-12. Here's what investors need to know before the announcement.
Analysts estimate that Acumen Pharmaceuticals will report an earnings per share (EPS) of $-0.66.
Investors in Acumen Pharmaceuticals are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.
It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.
Past Earnings Performance
The company's EPS missed by $0.15 in the last quarter, leading to a 0.79% increase in the share price on the following day.
Here's a look at Acumen Pharmaceuticals's past performance and the resulting price change:
| Quarter | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|
| EPS Estimate | -0.53 | -0.55 | -0.37 | -0.36 |
| EPS Actual | -0.68 | -0.48 | -0.62 | -0.50 |
| Price Change % | 1.00 | -7.00 | -3.00 | -5.00 |
Performance of Acumen Pharmaceuticals Shares
Shares of Acumen Pharmaceuticals were trading at $1.89 as of November 10. Over the last 52-week period, shares are down 23.72%. Given that these returns are generally negative, long-term shareholders are likely a little upset going into this earnings release.
To track all earnings releases for Acumen Pharmaceuticals visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.